Medical Science Liaison, Endocrinology – Mid-Atlantic Region jobs in United States
cer-icon
Apply on Employer Site
company-logo

Corcept Therapeutics · 5 months ago

Medical Science Liaison, Endocrinology – Mid-Atlantic Region

Corcept Therapeutics is a leader in the research and development of cortisol modulators, dedicated to advancing treatment possibilities for serious diseases. The Medical Science Liaison (MSL) will engage with healthcare professionals and thought leaders to build advocacy for Cushing’s syndrome and Corcept’s products, while providing scientific education and support for clinical trials and medical inquiries.

BiotechnologyMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Engage in clinically meaningful scientific discussion with thought leaders (TLs) and HCPs to build knowledge and advocacy for Cushing’s syndrome and Corcept’s FDA approved product(s)
Provide scientific presentations and educational programs to HCPs regarding Corcept’s products, disease states, and clinical trials
Develop and maintain strong working relationships with thought leaders (TLs) and organizations within the medical community
Proactively or responsively support Corcept products via healthcare professional communication and education
Respond to medical inquiries from HCPs in a timely and scientifically accurate manner
Generate scientific content intended for healthcare providers
Attend and participate in medical conferences and other scientific events
Able to critically review scientific literature and provide evidenced-based insights
Capture, analyze, synthesize, and report insights and intelligence from the medical and scientific community in a compliant manner in order to help inform decisions by Corcept
Support clinical trials, investigator-sponsored studies, scientific communications, publications, clinical and scientific education, advisory boards, and congresses
Maintain the highest standards of scientific, clinical, and technical expertise in relevant therapeutic area(s)
70% Travel required

Qualification

Clinical science degreeMSL experienceScientific presentationsProject managementInterpersonal skillsBusiness acumenIntellectual curiosityCommunication skillsTeamworkCollaborationDecision-making

Required

Strong clinical acumen and ability to engage in scientific discussions with TLs and HCPs on Corcept's therapeutic areas and products
Ability to critically review scientific literature and provide evidenced-based insights
Capture, analyze, synthesize, and report insights and intelligence from the medical and scientific community in a compliant manner
Support clinical trials, investigator-sponsored studies, scientific communications, publications, clinical and scientific education, advisory boards, and congresses
Maintain the highest standards of scientific, clinical, and technical expertise in relevant therapeutic area(s)
70% Travel required
Must maintain a driving record in accordance with Corcept vehicle policy

Preferred

Strong business acumen: has working knowledge of the multi-disciplinary functions involved in a company's drug development process, e.g. research, development, clinical operations, biostatistics, regulatory, commercial, etc
Exemplifies the following core competencies: intellectual curiosity, managing change, teamwork and collaboration, communication, achieving results, decision-making, and clinical and scientific expertise
Excellent project management skills: can prioritize multiple tasks and goals and ensure the timely, on-target, and within-budget accomplishment of such
Proven effective interpersonal and communication skills
Clinical science degree; advanced degree in medical science is required (MD, PhD, PharmD, NP, PA)
7+ years MSL experience with therapeutic area expertise highly preferred

Company

Corcept Therapeutics

twittertwittertwitter
company-logo
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.

Funding

Current Stage
Public Company
Total Funding
$119.09M
Key Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M

Leadership Team

leader-logo
Roberto Vieira
President, Oncology
linkedin
leader-logo
Yuan Xu
Associate Director, Statistical Programming
linkedin
Company data provided by crunchbase